Soy Research Today is a free monthly online journal that collates and summarizes the latest research about Soy, including details on soy milk, soy protein, soya bean, benefits, dangers.

Does insulin release kinins in rats?

Damas J, Garbacki N, Lefèbvre PJ

Department of Human Physiology, University of Liège, Avenue de l'Hôpital 3, Sart-Tilman, B-4000 Liège, Belgium.

Rat uterus maintained in situ was used as a bioassay of kinins possibly released in vivo by hyperglycaemia or insulin. Intravenous injections of bradykinin induced contractions of rat uterus which were suppressed by HOE 140, a bradykinin B2 receptor antagonist. Des-Arg9-bradykinin, a kinin B1 receptor agonist, did not elicit any response. After propranolol, the effects of bradykinin were enhanced and dose-dependent. This potentiation did not appear in adrenalectomized rats. Captopril, an angiotensin-converting enzyme (ACE) inhibitor, largely increased the effects of bradykinin. In animals pretreated with propranolol, captopril and atosiban, an oxytocin antagonist, intravenous infusion of glucose induced hyperglycaemia and after a delay increased the uterine contractile activity. This contractile effect of glucose was abolished by HOE 140. Infusion of insulin with glucose induced contractions of the uterus. These responses did not appear or were suppressed by HOE 140 or by soya bean trypsin inhibitor (SBTI), a plasma kallikrein inhibitor. These results are direct evidence that insulin induces a release of kinins.

Published 28 November 2005 in Eur J Pharmacol, 525(1): 154-60.
Full-text of this article is available online (may require subscription).

© 2004-2008 Soy Research Today. All Rights Reserved.